MK-0557
- Generic Name
- MK-0557
- Drug Type
- Small Molecule
- Chemical Formula
- C22H19FN4O3
- CAS Number
- 328232-95-7
- Unique Ingredient Identifier
- HVE36P8422
- Background
MK0557 has been investigated for the treatment of Schizophrenia and Paranoid Schizophrenia.
Schizophrenia Market Set for Strong Growth, Driven by Novel Therapies
• The schizophrenia market is expected to grow significantly, driven by the launch of novel therapies and increased diagnosis rates.
• Long-acting injectables (LAIs) are gaining traction despite higher costs, offering an alternative to oral antipsychotics.
• The US dominates the schizophrenia market due to a large patient population and high drug costs.
• Emerging treatments like Cobenfy, evenamide, Ingrezza, and iclepertin aim to address unmet needs in managing both positive and negative symptoms.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath